Sabre (SABR): Constellation’s most asymmetric bet
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
@MBrooks87621 $tenb
Activist Nelson Peltz Walked Away From the Investment He Loved Most. Now He’s Back. $WEN
@BryanFaulkCPA I bought the $PSA preferred and the $VNO preferred recently They have pretty good price appreciation on top on the solid yield now
Bear thesis for $HPP studio biz
Adient has $435 million of buyback capacity, equal to 38% of its market value, after adding $400 million to its repurchase program.
Knife River expects FY26 EBITDA margin to fall 138 basis points as project delays and fuel costs bite, while Sharper EDGE targets…
AST SpaceMobile’s 79% decline improves its risk-reward case, but satellite deployment delays, rising costs and Blacklift commitments raise…
India’s 236 GWh battery target boosts local electrolyte-salt makers, while Mirion’s radiation monitors and Overwatch’s passive drone…
Remitly’s Q3 revenue growth accelerated to 22% as lower transaction losses lifted margins, while recipient-facing products build a…
Dave & Buster’s faces fourteen straight quarters of same-store sales declines, shrinking margins and a new CEO’s turnaround plan after…
Chord Energy trades at 3x mid-cycle EV/EBITDA with a 15% free-cash-flow yield at $75 WTI, while repurchasing shares and expanding its…
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward…
Euroseas’ feeder-vessel renewals and contracted cash flow support higher 2027 earnings, while Red Sea normalization, vessel values and…
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
BNTC · long Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.
Corporacion America Airports has stayed operating-profitable through Argentina’s inflation and is diversifying airport assets beyond its…
Molson Coors, a 7% portfolio position, is the world’s fourth-largest brewer with leading beer shares in Canada and the US through Coors and…
Pitney Bowes has returned 60% in 2026 after divestitures, cost cuts, debt repayment and buybacks; its strategic review includes selling…
Bill Ackman discusses Pershing Square’s new listed investment vehicle and the plan to turn Howard Hughes into a long-term compounding…
PesoRama’s 0.64 current ratio, operating cash burn and 111% annual dilution offset 36% Q1 revenue growth, despite replacing an 18.5% loan…
VEON’s 84% Kyivstar stake and JazzCash underpin a sum-of-the-parts case for 4x upside, despite its sanctioned shareholder, capital…
Constellium supplies aluminum-lithium alloy 2195 for Falcon 9 tanks and aerospace programs, with qualification barriers supporting…
MSA Safety’s Pershing Square Challenge finalists pitch gas-detection subscriptions, mandated SCBA replacement cycles and a 2023 liability…
Fermi, a $6 billion Texas power developer with 17 gigawatts of planned capacity, needs its first data-center lease before turbine financing…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.